Skip to main content
. 2016 Oct 26;7(49):80262–80274. doi: 10.18632/oncotarget.12918

Figure 1. Andrographolide treatment ameliorated OVA-induced recruitment of inflammatory cells and lung injury in mice.

Figure 1

Mice were changed with OVA and treated with Andrographolide (5 and 10 mg/kg). A. BALF (bronchoalveolar lavage fluid) from each group was gathered and cells in BALF were counted. Then they were stained with CD3-FITC, CD11b-PE, CD11c-APC and analyzed by FACS. B. Lung tissue were fixed in 4% formalin and subjected to hematoxylin/eosin (H&E) staining. Values were shown as the means ± SEM of eight mice. *P < 0.05, **P < 0.01 vs. mice treated with OVA alone. Scale bar 50 μm.